Amedeo Smart

Free Medical Literature Service


 

Amedeo

Anemia

  Free Subscription

Articles published in
Ann Hematol
    September 2021
  1. THONG EWS, Tan SS, Sethi SK, Chee YL, et al
    Falsely elevated serum vitamin B12 levels in a case of pernicious anemia.
    Ann Hematol. 2021 Sep 10. pii: 10.1007/s00277-021-04612.
    >> Share

  2. WOUTERS HJCM, Conrads-Frank A, Koinig KA, Smith A, et al
    The anemia-independent impact of myelodysplastic syndromes on health-related quality of life.
    Ann Hematol. 2021 Sep 2. pii: 10.1007/s00277-021-04654.
    >> Share

  3. JANG T, Mo G, Stewart C, Khoury L, et al
    Obesity and diabetes mellitus in patients with sickle cell disease.
    Ann Hematol. 2021;100:2203-2205.
    >> Share

  4. BOGA C, Asma S, Leblebisatan G, Sen N, et al
    Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.
    Ann Hematol. 2021;100:2195-2202.
    >> Share

    August 2021
  5. CHENOU F, Hounkpe BW, Domingos IF, Tonasse WV, et al
    Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.
    Ann Hematol. 2021 Aug 28. pii: 10.1007/s00277-021-04636.
    >> Share

  6. YAMADA S, Kajikawa S, Nakagawa N, Kondo Y, et al
    Coombs' test positive autoimmune hemolytic anemia accompanied by myelodysplastic syndrome that became Coombs' test negative after azacitidine administration.
    Ann Hematol. 2021 Aug 27. pii: 10.1007/s00277-021-04652.
    >> Share

  7. ATIPIMONPAT A, Siwaponanan P, Khuhapinant A, Svasti S, et al
    Extracellular vesicles from thalassemia patients carry iron-containing ferritin and hemichrome that promote cardiac cell proliferation.
    Ann Hematol. 2021;100:1929-1946.
    >> Share

  8. TRANEKAER S, Hansen DL, Biemond BJ, Sorensen AL, et al
    Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study.
    Ann Hematol. 2021;100:1947-1951.
    >> Share

  9. SINGHA K, Fucharoen G, Fucharoen S
    delta-Hemoglobinopathies in Thailand: screening, molecular basis, genotype-phenotype interaction, and implication for prevention and control of thalassemia.
    Ann Hematol. 2021;100:1953-1963.
    >> Share

  10. HOSOKAWA K, Ishiyama K, Ikemoto T, Sugimori C, et al
    The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure.
    Ann Hematol. 2021;100:1975-1982.
    >> Share

    July 2021
  11. NORASETTHADA L, Wongkhantee S, Chaipokam J, Charoenprasert K, et al
    Adult aplastic anemia in Thailand: incidence and treatment outcome from a prospective nationwide population-based study.
    Ann Hematol. 2021 Jul 16. pii: 10.1007/s00277-021-04566.
    >> Share

  12. YANG W, Zhao X, Peng G, Zhang L, et al
    Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia.
    Ann Hematol. 2021 Jul 16. pii: 10.1007/s00277-021-04553.
    >> Share

  13. CAO J, Pei R, Zhang P, Liu X, et al
    Successful haploidentical transplantation using plasma exchange and post-transplantation cyclophosphamide for severe aplastic anemia patients with anti-human leukocyte antigen donor-specific antibodies.
    Ann Hematol. 2021 Jul 6. pii: 10.1007/s00277-021-04497.
    >> Share

  14. GOREN SAHIN D, Akay OM, Keklik M, Okan V, et al
    Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.
    Ann Hematol. 2021;100:1667-1675.
    >> Share

  15. ELZAEEM DI, Sharkawi EAE, Zaki EM, Ghobrial AG, et al
    Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients.
    Ann Hematol. 2021;100:1701-1709.
    >> Share

  16. NJUE L, Medri C, Keller P, Diepold M, et al
    The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature review.
    Ann Hematol. 2021;100:1677-1683.
    >> Share

    June 2021
  17. BATISTA JVGF, Pereira-Martins DA, Falcao DA, Domingos IF, et al
    Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia.
    Ann Hematol. 2021 Jun 14. pii: 10.1007/s00277-021-04532.
    >> Share

  18. KRECAK I, Cengic M, Skoric I, Nakic M, et al
    Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib.
    Ann Hematol. 2021 Jun 10. pii: 10.1007/s00277-021-04570.
    >> Share

  19. AL-TAWFIQ JA, Rabaan AA, AlEdreesi MH
    Frequency of bacteremia in patients with sickle cell disease: a longitudinal study.
    Ann Hematol. 2021;100:1411-1416.
    >> Share

  20. ARPACI A, Gul BU, Ozcan O, Ilhan G, et al
    Presentation of two new mutations in the 3'untranslated region of the beta-globin gene and evaluating the molecular spectrum of thalassemia mutations in the Mediterranean region of Turkey.
    Ann Hematol. 2021;100:1429-1438.
    >> Share

  21. BHURANI D, Kapoor J, Yadav N, Khushoo V, et al
    Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients.
    Ann Hematol. 2021;100:1417-1427.
    >> Share

  22. MAROUF R, Adekile AD, El-Muzaini H, Abdulla R, et al
    Neutrophil gelatinase-associated lipocalin as a biomarker of nephropathy in sickle cell disease.
    Ann Hematol. 2021;100:1401-1409.
    >> Share

    May 2021
  23. HERBRETEAU L, Le Calloch R, Arnaud B, Cassou N, et al
    Eculizumab, a real-life successful treatment for refractory cold agglutinin-mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders.
    Ann Hematol. 2021 May 18. pii: 10.1007/s00277-021-04557.
    >> Share

  24. QIN X, Zhu YP, Luo CJ, Zhou M, et al
    Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6-7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years.
    Ann Hematol. 2021 May 14. pii: 10.1007/s00277-021-04540.
    >> Share

  25. BALLAS SK
    Opioids are not a major cause of death of patients with sickle cell disease.
    Ann Hematol. 2021;100:1133-1138.
    >> Share

    April 2021
  26. MENDOZA E, Duque X, Moran S, Martinez-Andrade G, et al
    Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants.
    Ann Hematol. 2021;100:879-890.
    >> Share

  27. RAMSAY Z, Gabbadon CH, Asnani M
    Numb chin syndrome in sickle cell disease: a case series of Jamaican patients.
    Ann Hematol. 2021;100:913-919.
    >> Share

  28. HATAIRAKTHAM S, Masaratana P, Hantaweepant C, Srisawat C, et al
    Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent beta-thalassemia/Hb E patients.
    Ann Hematol. 2021;100:891-901.
    >> Share

    March 2021
  29. YOUSSEF JG, Zahiruddin F, Youssef G, Padmanabhan S, et al
    G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
    Ann Hematol. 2021;100:667-673.
    >> Share

  30. SAEIDNIA M, Nowrouzi-Sohrabi P, Erfani M, Fazeli P, et al
    The effect of curcumin on serum copper, zinc, and zinc/copper ratio in patients with beta-thalassemia intermedia: a randomized double-blind clinical trial.
    Ann Hematol. 2021;100:627-633.
    >> Share

  31. VERMA HK, Ratre YK, Bhaskar LVKS, Colombatti R, et al
    Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy.
    Ann Hematol. 2021;100:607-614.
    >> Share

  32. HAGHPANAH S, Cohan N, Bordbar M, Bazrafshan A, et al
    Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent beta-thalassemia.
    Ann Hematol. 2021;100:635-644.
    >> Share

  33. SCHULLER H, Klein F, Lubbert M, Prager EP, et al
    Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report.
    Ann Hematol. 2021;100:841-842.
    >> Share

  34. MISTRY RH, Kohut A, Ford P
    Correction of iron deficiency in hospitalized heart failure patients does not improve patient outcomes.
    Ann Hematol. 2021;100:661-666.
    >> Share

    February 2021
  35. HSIEH TC, Sostin O
    Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids.
    Ann Hematol. 2021 Feb 18. pii: 10.1007/s00277-021-04457.
    >> Share

  36. HATZLHOFER BLD, Pereira-Martins DA, de Farias Domingos I, Arcanjo GDS, et al
    Alpha thalassemia, but not beta(S)-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort.
    Ann Hematol. 2021 Feb 13. pii: 10.1007/s00277-021-04450.
    >> Share

  37. LADEIRA VS, Barbosa AR, Oliveira MM, Ferreira LGR, et al
    ADAMTS-13-VWF axis in sickle cell disease patients.
    Ann Hematol. 2021;100:375-382.
    >> Share

  38. KUMAR R, Yadav R, Mishra S, Singh MPSS, et al
    Kruppel-like factor 1 (KLF1) gene single nucleotide polymorphisms in sickle cell disease and its association with disease-related morbidities.
    Ann Hematol. 2021;100:365-373.
    >> Share

  39. BATISTA JVGF, Arcanjo GS, Batista THC, Sobreira MJ, et al
    Influence of UGT1A1 promoter polymorphism, alpha-thalassemia and beta(s) haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort.
    Ann Hematol. 2021 Feb 1. pii: 10.1007/s00277-021-04422.
    >> Share

    January 2021
  40. MARTYNOVA A, Chiu V, Mert M, Hermel D, et al
    Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series.
    Ann Hematol. 2021 Jan 9. pii: 10.1007/s00277-021-04401.
    >> Share

  41. STACY S, Sheth S, Coleman B, Cerenzia W, et al
    An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia.
    Ann Hematol. 2021;100:27-35.
    >> Share

    December 2020
  42. GIORDANO G, Napolitano M, Di Battista V, Lucchesi A, et al
    Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study.
    Ann Hematol. 2020 Dec 2. pii: 10.1007/s00277-020-04361.
    >> Share

  43. WU Y, Yao Q, Zhong M, Wu J, et al
    Genetic research and clinical analysis of deletional Chinese (G)gamma(+)((A)gammadeltabeta)(0) -thalassemia and Southeast Asian HPFH in South China.
    Ann Hematol. 2020;99:2747-2753.
    >> Share

  44. SINHA S, Jit BP, Patro ARK, Ray A, et al
    Influence of rs1042713 and rs1042714 polymorphisms of beta2-adrenergic receptor gene with erythrocyte cAMP in sickle cell disease patients from Odisha State, India.
    Ann Hematol. 2020;99:2737-2745.
    >> Share

  45. PAZGAL I, Yahalom V, Shalev B, Raanani P, et al
    Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel.
    Ann Hematol. 2020;99:2731-2736.
    >> Share

    November 2020
  46. MENDEZ M, Moreno-Carralero MI, Peri VL, Camacho-Galan R, et al
    Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene.
    Ann Hematol. 2020 Nov 7. pii: 10.1007/s00277-020-04319.
    >> Share

  47. RUAN J, Zuo W, Chen M, Yang C, et al
    Correction to: Eltrombopag is effective in patients with relapse/refractory aplastic anemia-report from a single center in China.
    Ann Hematol. 2020 Nov 2. pii: 10.1007/s00277-020-04301.
    >> Share

  48. ABDULLAH N, Ismail N, Abd Jalal N, Mohd Radin F, et al
    Prevalence of anaemia and associated risk factors amongst The Malaysian Cohort participants.
    Ann Hematol. 2020;99:2521-2527.
    >> Share

  49. DESAI RJ, Mahesri M, Globe D, Mutebi A, et al
    Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries.
    Ann Hematol. 2020;99:2497-2505.
    >> Share

  50. BALLAS SK, Dampier C
    Risk factors associated with increased emergency department utilization in patients with sickle cell disease: a systematic literature review.
    Ann Hematol. 2020;99:2483-2495.
    >> Share

  51. KIRITO K
    Expansion of paroxysmal nocturnal hemoglobinuria clones in MPLW515L mutation harboring primary myelofibrosis.
    Ann Hematol. 2020;99:2707-2709.
    >> Share

  52. TRIPATHI P, Agarwal S, Gupta A, Mandal K, et al
    Biallelic rare 17 bp deletion mutation (HBB:c.380_396 del TGCAGGCTGCCTATCAG) in a transfusion depended form of thalassemia.
    Ann Hematol. 2020;99:2719-2722.
    >> Share

    October 2020
  53. WAN K, Yin Y, Luo Z, Cheng J, et al
    Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia.
    Ann Hematol. 2020 Oct 16. pii: 10.1007/s00277-020-04300.
    >> Share

  54. ONISHI Y, Mori T, Yamazaki H, Takenaka K, et al
    Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia.
    Ann Hematol. 2020 Oct 9. pii: 10.1007/s00277-020-04290.
    >> Share

  55. LAN Y, Chang L, Yi M, Cai Y, et al
    Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine.
    Ann Hematol. 2020 Oct 8. pii: 10.1007/s00277-020-04296.
    >> Share

  56. ONISHI Y, Yokoyama H, Katsuoka Y, Ito T, et al
    Low-dose lenalidomide and dexamethasone therapy after melphalan-prednisolone induction in elderly patients with newly diagnosed multiple myeloma.
    Ann Hematol. 2020;99:2351-2356.
    >> Share

  57. FUREDER W, Sperr WR, Heibl S, Zebisch A, et al
    Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network.
    Ann Hematol. 2020;99:2303-2313.
    >> Share

  58. BUTTARI B, Profumo E, Caprari P, Massimi S, et al
    Phenotypical and functional abnormalities of circulating neutrophils in patients with beta-thalassemia.
    Ann Hematol. 2020;99:2265-2277.
    >> Share

  59. EL-GHAMRAWY M, Yassa ME, Tousson AMS, El-Hady MA, et al
    Association between BCL11A, HSB1L-MYB, and XmnI gammaG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
    Ann Hematol. 2020;99:2279-2288.
    >> Share

  60. CHUANG TY, Li JP, Weng TF, Wu KH, et al
    Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications.
    Ann Hematol. 2020;99:2289-2294.
    >> Share

  61. FRIEDRICH C, Gay J, Alary AS, Arlet JB, et al
    Battle of the clones: paroxysmal nocturnal hemoglobinuria vs myelodysplastic syndrome.
    Ann Hematol. 2020;99:2459-2461.
    >> Share

    September 2020
  62. DREXLER B, Zurbriggen F, Diesch T, Viollier R, et al
    Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation.
    Ann Hematol. 2020 Sep 19. pii: 10.1007/s00277-020-04271.
    >> Share

  63. WAN K, Yin Y, Luo Z, Cheng J, et al
    Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia.
    Ann Hematol. 2020 Sep 17. pii: 10.1007/s00277-020-04269.
    >> Share

  64. RUAN J, Zuo W, Chen M, Yang C, et al
    Eltrombopag is effective in patients with relapse/refractory aplastic anemia-report from a single center in China.
    Ann Hematol. 2020 Sep 17. pii: 10.1007/s00277-020-04266.
    >> Share

  65. ASLEH M, Levitas A, Daniel S, Abu-Quider A, et al
    Hepatic and cardiac iron load as determined by MRI T2* in patients with congenital dyserythropoietic anemia type I.
    Ann Hematol. 2020 Sep 12. pii: 10.1007/s00277-020-04263.
    >> Share

  66. ALGASSIM AA, Elghazaly AA, Alnahdi AS, Mohammed-Rahim OM, et al
    Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection.
    Ann Hematol. 2020 Sep 12. pii: 10.1007/s00277-020-04256.
    >> Share

  67. GIANESIN B, Pinto VM, Casale M, Corti P, et al
    Manual erythroexchange in sickle cell disease: multicenter validation of a protocol predictive of volume to exchange and hemoglobin values.
    Ann Hematol. 2020;99:2047-2055.
    >> Share

  68. SHRESTHA O, Khadwal AR, Singhal M, Trehan A, et al
    A high frequency of Gilbert syndrome (UGT1A1*28/*28) and associated hyperbilirubinemia but not cholelithiasis in adolescent and adult north Indian patients with transfusion-dependent beta-thalassemia.
    Ann Hematol. 2020;99:2019-2026.
    >> Share

  69. SALIBA AN, Atoui A, Labban M, Hamade H, et al
    Thalassemia in the emergency department: special considerations for a rare disease.
    Ann Hematol. 2020;99:1967-1977.
    >> Share

  70. BORTOLOTTI M, D'Ambrosio R, Fraquelli M, Pedrotti P, et al
    Liver damage and sickle cell disease: genotype relationship.
    Ann Hematol. 2020;99:2065-2072.
    >> Share

  71. NUALKAEW T, Khamphikham P, Pongpaksupasin P, Kaewsakulthong W, et al
    UNC0638 induces high levels of fetal hemoglobin expression in beta-thalassemia/HbE erythroid progenitor cells.
    Ann Hematol. 2020;99:2027-2036.
    >> Share

  72. DAAR S, Al Khabori M, Al Rahbi S, Hassan M, et al
    Cardiac T2* MR in patients with thalassemia major: a 10-year long-term follow-up.
    Ann Hematol. 2020;99:2009-2017.
    >> Share

  73. RHODES A, Martin S, Wolters P, Rodriguez Y, et al
    Sleep disturbance in adults with sickle cell disease: relationships with executive and psychological functioning.
    Ann Hematol. 2020;99:2057-2064.
    >> Share

  74. DIMITROGLOU Y, Anagnostopoulos F, Aggeli C, Delicou S, et al
    Severity of heart failure and health-related quality of life in beta-thalassemia patients: a cross-sectional study.
    Ann Hematol. 2020;99:2037-2046.
    >> Share

  75. DESAI R, Bansod S, Patel U
    Nationwide prevalence and trends in acute cardiovascular events and in-hospital mortality among adult African Americans with sickle cell trait.
    Ann Hematol. 2020;99:2207-2209.
    >> Share

  76. ANTWI-BOASIAKO C, Andemariam B, Colombatti R, Asare EV, et al
    A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis.
    Ann Hematol. 2020;99:2073-2079.
    >> Share

    August 2020
  77. LONG Z, Li H, Du Y, Chen M, et al
    Gene mutation profile in patients with acquired pure red cell aplasia.
    Ann Hematol. 2020;99:1749-1754.
    >> Share

  78. HUSCENOT T, Galland J, Ouvrat M, Rossignol M, et al
    SARS-CoV-2-associated cold agglutinin disease: a report of two cases.
    Ann Hematol. 2020;99:1943-1944.
    >> Share

  79. LI L, Li Y, Lin L, Yin J, et al
    Outcomes of allogeneic haematopoietic stem cell transplantation for patients with severe aplastic anaemia using the porcine antilymphocyte globulin-containing conditioning regimen.
    Ann Hematol. 2020;99:1863-1871.
    >> Share

  80. LANCMAN G, Marcellino BK, Thibaud S, Troy K, et al
    Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19.
    Ann Hematol. 2020 Aug 1. pii: 10.1007/s00277-020-04202.
    >> Share

    July 2020
  81. SERVATYARI K, Moradveisi B, Yazdanpanah H, Bacigalupo A, et al
    A 30-month-old boy with aplastic anemia caused by electrocution.
    Ann Hematol. 2020 Jul 24. pii: 10.1007/s00277-020-04189.
    >> Share

  82. BETTELLI F, Giusti D, Morselli M, Colaci E, et al
    Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study.
    Ann Hematol. 2020 Jul 23. pii: 10.1007/s00277-020-04191.
    >> Share

  83. KANG KW, Moon H, Lee BH, Jeon MJ, et al
    Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab.
    Ann Hematol. 2020;99:1493-1503.
    >> Share

  84. HARIHARAN P, Kishnani P, Sawant P, Gorivale M, et al
    Genotypic-phenotypic heterogeneity of deltabeta-thalassemia and hereditary persistence of fetal hemoglobin (HPFH) in India.
    Ann Hematol. 2020;99:1475-1483.
    >> Share

  85. CHEN Z, Chen M, Yang C, Han B, et al
    Immunosuppression therapy is effective for both acquired tumor-associated and primary pure red cell aplasia: a match pair case-control study.
    Ann Hematol. 2020;99:1485-1491.
    >> Share

  86. GARCIA-MORIN M, Bardon-Cancho EJ, Belendez C, Zamarro R, et al
    Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country.
    Ann Hematol. 2020;99:1465-1474.
    >> Share

  87. SCHREZENMEIER H, Roth A, Araten DJ, Kanakura Y, et al
    Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry.
    Ann Hematol. 2020;99:1505-1514.
    >> Share

    June 2020
  88. HUO J, Li X, Shao Y, Ren X, et al
    Long-term follow-up of a novel immunosuppressive strategy of cyclosporine alternatively combined with levamisole for severe aplastic anemia.
    Ann Hematol. 2020 Jun 29. pii: 10.1007/s00277-020-04153.
    >> Share

  89. AMES PRJ, Jeffrey S
    Bortezomib and rituximab in multiply relapsed primary warm autoimmune hemolytic anemia.
    Ann Hematol. 2020 Jun 17. pii: 10.1007/s00277-020-04135.
    >> Share

  90. HOCHMAN MJ, Martin DB
    Coincidence of autoimmune hemolytic anemia and pure red cell aplasia in a patient with CLL.
    Ann Hematol. 2020 Jun 16. pii: 10.1007/s00277-020-04091.
    >> Share

  91. CAPES A, Bailly S, Hantson P, Gerard L, et al
    COVID-19 infection associated with autoimmune hemolytic anemia.
    Ann Hematol. 2020 Jun 16. pii: 10.1007/s00277-020-04137.
    >> Share

  92. KRECAK I, Supe M, Ilic I, Gveric-Krecak V, et al
    Behet-like syndrome associated with aplastic anemia successfully treated with mycophenolate mofetil.
    Ann Hematol. 2020 Jun 13. pii: 10.1007/s00277-020-04119.
    >> Share

  93. GAUT D, Jones J, Chen C, Ghafouri S, et al
    Outcomes related to intravenous fluid administration in sickle cell patients during vaso-occlusive crisis.
    Ann Hematol. 2020;99:1217-1223.
    >> Share

  94. RICCHI P, Meloni A, Costantini S, Spasiano A, et al
    Red blood cell consumption in a large cohort of patients with thalassaemia: a retrospective analysis of main predictors.
    Ann Hematol. 2020;99:1209-1215.
    >> Share

    May 2020
  95. SALES RR, Belisario AR, Faria G, Mendes F, et al
    Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
    Ann Hematol. 2020 May 23. pii: 10.1007/s00277-020-04079.
    >> Share

  96. XU M, Zhao X, Sun F, Zhu R, et al
    A case of iron deficiency anemia with extremely hyperferritinemia responds well to oral iron: the first identified hereditary hyperferritinemia cataract syndrome in China.
    Ann Hematol. 2020 May 20. pii: 10.1007/s00277-020-04085.
    >> Share

  97. JAIN A, Gupta DK
    Daratumumab for refractory warm autoimmune hemolytic anemia.
    Ann Hematol. 2020 May 14. pii: 10.1007/s00277-020-04063.
    >> Share

  98. ALVES AC, da Silva VAL, Dos Santos A, Serra MB, et al
    Sickle cell anemia in the state of Maranhao: a haplotype study.
    Ann Hematol. 2020 May 4. pii: 10.1007/s00277-020-04048.
    >> Share

  99. SVIDNICKI MCCM, Zanetta GK, Congrains-Castillo A, Costa FF, et al
    Targeted next-generation sequencing identified novel mutations associated with hereditary anemias in Brazil.
    Ann Hematol. 2020;99:955-962.
    >> Share

  100. SHAH F, Dwivedi M
    Pathophysiology and recent therapeutic insights of sickle cell disease.
    Ann Hematol. 2020;99:925-935.
    >> Share

    April 2020
  101. MIHAILESCU AM, Musallam KM, Cappellini MD, Taher AT, et al
    Less 'reds' more 'blues': hemoglobin level and depression in non-transfusion-dependent thalassemia.
    Ann Hematol. 2020;99:903-904.
    >> Share

  102. MORE TA, Dongerdiye R, Devendra R, Warang PP, et al
    Mechanosensitive Piezo1 ion channel protein (PIEZO1 gene): update and extended mutation analysis of hereditary xerocytosis in India.
    Ann Hematol. 2020;99:715-727.
    >> Share

  103. AZMAN NF, Abdullah WZ, Hanafi S, Diana R, et al
    Genetic polymorphisms of HbE/beta thalassemia related to clinical presentation: implications for clinical diversity.
    Ann Hematol. 2020;99:729-735.
    >> Share

  104. BEWERSDORF JP, Zeidan AM
    Evolving therapies for lower-risk myelodysplastic syndromes.
    Ann Hematol. 2020;99:677-692.
    >> Share

  105. CHEN Z, Liu X, Chen M, Yang C, et al
    Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency.
    Ann Hematol. 2020;99:737-741.
    >> Share

    March 2020
  106. JAMWAL M, Aggarwal A, Sharma P, Bansal D, et al
    Congenital dyserythropoietic anemia type IV with high fetal hemoglobin caused by heterozygous KLF1 p.Glu325Lys: first report in an Indian infant.
    Ann Hematol. 2020 Mar 27. pii: 10.1007/s00277-020-03982.
    >> Share

  107. RENO CO, Barbosa AR, de Carvalho SS, Pinheiro MB, et al
    Oxidative stress assessment in sickle cell anemia patients treated with hydroxyurea.
    Ann Hematol. 2020 Mar 12. pii: 10.1007/s00277-020-03987.
    >> Share

  108. CHEN M, Zhuang J, Yang C, Zhang L, et al
    Rapid response to a single-dose rituximab combined with bortezomib in refractory and relapsed warm autoimmune hemolytic anemia.
    Ann Hematol. 2020 Mar 7. pii: 10.1007/s00277-020-03976.
    >> Share

  109. DOMINGOS IF, Pereira-Martins DA, Sobreira MJVC, Oliveira RTD, et al
    High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia.
    Ann Hematol. 2020 Mar 5. pii: 10.1007/s00277-020-03978.
    >> Share

  110. DE LUNA G, Darnige L, Roueff S, Peyrard T, et al
    Usefulness of azacitidine therapy in a sickle cell disease patient with myelodysplastic syndrome.
    Ann Hematol. 2020;99:661-662.
    >> Share

  111. SHOKRGOZAR N, Amirian N, Ranjbaran R, Bazrafshan A, et al
    Evaluation of regulatory T cells frequency and FoxP3/GDF-15 gene expression in beta-thalassemia major patients with and without alloantibody; correlation with serum ferritin and folate levels.
    Ann Hematol. 2020;99:421-429.
    >> Share

  112. LIU X, Lu X, Chen L, Yang Y, et al
    Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective.
    Ann Hematol. 2020;99:443-449.
    >> Share

    February 2020
  113. PEFFAULT DE LATOUR R, Huynh L, Ivanova JI, Totev T, et al
    Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study.
    Ann Hematol. 2020 Feb 17. pii: 10.1007/s00277-019-03809.
    >> Share

  114. NICOLETTI E, Rao G, Bueren JA, Rio P, et al
    Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.
    Ann Hematol. 2020 Feb 17. pii: 10.1007/s00277-020-03954.
    >> Share

    January 2020
  115. RUSSO G, Guardabasso V, Romano F, Corti P, et al
    Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica).
    Ann Hematol. 2020 Jan 21. pii: 10.1007/s00277-020-03906.
    >> Share

  116. EL-GAMAL RAE, Abdel-Messih IY, Habashy DM, Zaiema SEG, et al
    Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia.
    Ann Hematol. 2020;99:31-39.
    >> Share

    December 2019
  117. QIU Y, Cai H, Cui L, Liu YX, et al
    Identification of a novel heterozygous ALAS2 mutation in a young Chinese female with X-linked sideroblastic anemia.
    Ann Hematol. 2019 Dec 17. pii: 10.1007/s00277-019-03894.
    >> Share

  118. KAUNDAL R, Bhatia P, Jain A, Jain A, et al
    Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia.
    Ann Hematol. 2019 Dec 6. pii: 10.1007/s00277-019-03871.
    >> Share

  119. PARK S, Kelaidi C, Meunier M, Casadevall N, et al
    Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.
    Ann Hematol. 2019 Dec 2. pii: 10.1007/s00277-019-03874.
    >> Share

  120. LAURENTINO MR, Parente Filho SLA, Parente LLC, da Silva Junior GB, et al
    Non-invasive urinary biomarkers of renal function in sickle cell disease: an overview.
    Ann Hematol. 2019;98:2653-2660.
    >> Share

  121. YINGJUN X, Yuhuan X, Yuchang C, Dongzhi L, et al
    CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells.
    Ann Hematol. 2019;98:2661-2671.
    >> Share

    November 2019
  122. LV X, Dong S, Lan F, Zhang B, et al
    Congenital dyserythropoietic anemia type I mimicking myelodysplasia syndrome with a novel CDAN1 mutation.
    Ann Hematol. 2019 Nov 23. pii: 10.1007/s00277-019-03848.
    >> Share

  123. SABUNCUOGLU S, Oztas Y, Yalcinkaya A, Unal S, et al
    The increased neopterin content in turkish pediatric patients with sickle cell anemia.
    Ann Hematol. 2019 Nov 23. pii: 10.1007/s00277-019-03817.
    >> Share

  124. OLATUNYA OS, Lanaro C, Longhini AL, Penteado CFF, et al
    Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients.
    Ann Hematol. 2019;98:2507-2521.
    >> Share

  125. MASY V, Sokal E, Ranguelov N, Brichard B, et al
    Fatal type B lactic acidosis in a patient with end-stage liver disease related to homozygous sickle cell disease.
    Ann Hematol. 2019;98:2627-2628.
    >> Share

    October 2019
  126. CHOQUE-QUISPE BM, Paz V, Gonzales GF
    Proportion of anemia attributable to iron deficiency in high-altitude infant populations.
    Ann Hematol. 2019 Oct 30. pii: 10.1007/s00277-019-03823.
    >> Share

  127. PARK S, Kelaidi C, Meunier M, Casadevall N, et al
    The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.
    Ann Hematol. 2019 Oct 25. pii: 10.1007/s00277-019-03799.
    >> Share

  128. HUSCENOT T, Darnige L, Wagner-Ballon O, Ronchetti AM, et al
    Iron deficiency, an unusual cause of thrombocytopenia: results from a multicenter retrospective case-controlled study.
    Ann Hematol. 2019;98:2299-2302.
    >> Share

  129. TAKAHASHI T, Ichikawa S, Harigae H
    Successful cord blood transplantation for a paroxysmal nocturnal hemoglobinuria complicated with Budd-Chiari syndrome and myelodysplastic syndrome.
    Ann Hematol. 2019;98:2427-2428.
    >> Share

  130. HUANG Y, Liu X, Chen F, Zhou W, et al
    Prediction of thrombosis risk in patients with paroxysmal nocturnal hemoglobinuria.
    Ann Hematol. 2019;98:2283-2291.
    >> Share

  131. KARIMI M, Haghpanah S, Pishdad P, Zahedi Z, et al
    Frequency of silent brain lesions and aspirin protection evaluation over 3 years follow-up in beta thalassemia patients.
    Ann Hematol. 2019;98:2267-2271.
    >> Share

  132. KIM JS, Cheong JW, Mun YC, Jang JH, et al
    Clinical implication of renal dysfunction during the clinical course in patients with paroxysmal nocturnal hemoglobinuria: a longitudinal analysis.
    Ann Hematol. 2019;98:2273-2281.
    >> Share

    September 2019
  133. NICOLAU M, Vargas S, Silva M, Coelho A, et al
    Genetic modulators of fetal hemoglobin expression and ischemic stroke occurrence in African descendant children with sickle cell anemia.
    Ann Hematol. 2019 Sep 2. pii: 10.1007/s00277-019-03783.
    >> Share

  134. SRINOUN K, Sathirapongsasuti N, Paiboonsukwong K, Sretrirutchai S, et al
    miR-144 regulates oxidative stress tolerance of thalassemic erythroid cell via targeting NRF2.
    Ann Hematol. 2019;98:2045-2052.
    >> Share

    August 2019
  135. MEHER S, Patel S, Das K, Dehury S, et al
    Association of plasma homocysteine level with vaso-occlusive crisis in sickle cell anemia patients of Odisha, India.
    Ann Hematol. 2019 Aug 22. pii: 10.1007/s00277-019-03776.
    >> Share

  136. NG DB, Schiller G, Ha E
    Autoimmune hemolytic anemia in refractory hairy cell leukemia on dabrafenib and trametinib.
    Ann Hematol. 2019 Aug 13. pii: 10.1007/s00277-019-03780.
    >> Share

  137. RAY R, Kalantri SA, Bhattacharjee S, Biswas A, et al
    Association of alpha hemoglobin-stabilizing protein (AHSP) gene mutation and disease severity among HbE-beta thalassemia patients.
    Ann Hematol. 2019;98:1827-1834.
    >> Share

  138. LIN X, Cheng B, Cai Y, Jiao X, et al
    Establishing and evaluating an auto-verification system of thalassemia gene detection results.
    Ann Hematol. 2019;98:1835-1844.
    >> Share

    July 2019
  139. SHIMIZU R, Takeuchi M, Sakaida E, Ohwada C, et al
    Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation.
    Ann Hematol. 2019;98:1781-1783.
    >> Share

  140. NIEDEGGEN C, Singer S, Groth M, Petermann-Meyer A, et al
    Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)-a report on phase III.
    Ann Hematol. 2019;98:1547-1559.
    >> Share

  141. ARMENIS I, Kalotychou V, Tzanetea R, Moyssakis I, et al
    Reduced peripheral blood superoxide dismutase 2 expression in sickle cell disease.
    Ann Hematol. 2019;98:1561-1572.
    >> Share

  142. VOSKARIDOU E, Ntanasis-Stathopoulos I, Christoulas D, Dimopoulou M, et al
    Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density.
    Ann Hematol. 2019;98:1583-1592.
    >> Share

  143. DE LA FUENTE-GONZALO F, Nieto JM, Villegas A, Gonzalez FA, et al
    Characterization of deletional and non-deletional alpha globin variants in a large cohort from Spain between 2009 and 2014.
    Ann Hematol. 2019;98:1537-1545.
    >> Share

  144. SIRIVADHANAKUL P, Chuansumrit A, Songdej D, Kadegasem P, et al
    Increased endothelial activation in alpha-thalassemia disease.
    Ann Hematol. 2019;98:1593-1602.
    >> Share

    June 2019
  145. SU S, Liu Z, Wang F, Zhang Y, et al
    Aplastic anemia associated with Crohn's disease: a tertiary center retrospective study.
    Ann Hematol. 2019 Jun 29. pii: 10.1007/s00277-019-03729.
    >> Share

  146. JORGE SE, Lanaro C, Albuquerque DM, Nascimento PH, et al
    Hb Fairfax [HBB:c.285_286insGAGCTGCACTGTGAC] in a Brazilian patient with severe hemolytic anemia-identification and functional study.
    Ann Hematol. 2019 Jun 28. pii: 10.1007/s00277-019-03728.
    >> Share

  147. SOLTERMANN Y, Heim D, Medinger M, Baldomero H, et al
    Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study.
    Ann Hematol. 2019;98:1485-1493.
    >> Share

  148. RICCHI P, Meloni A, Grigoratos C, Toia P, et al
    Prevalence of extramedullary hematopoiesis, renal cysts, splenic and hepatic lesions, and vertebral hemangiomas among thalassemic patients: a retrospective study from the Myocardial Iron Overload in Thalassemia (MIOT) network.
    Ann Hematol. 2019;98:1333-1339.
    >> Share

  149. TRAKADA G, Kastritis E, Gavriatopoulou M, Velentza L, et al
    Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome.
    Ann Hematol. 2019;98:1427-1434.
    >> Share

  150. KOOHI F, Kazemi T, Miri-Moghaddam E
    Cardiac complications and iron overload in beta thalassemia major patients-a systematic review and meta-analysis.
    Ann Hematol. 2019;98:1323-1331.
    >> Share

    May 2019
  151. LI Y, Zhang Z, Yang L, Li X, et al
    Colla corii asini might upregulate ZNF471 and THOC5 by KRAB domain-containing zinc-finger protein pathway and THO complex subunit 5 pathway to improve anemia of pregnant women with beta-thalassemia.
    Ann Hematol. 2019 May 16. pii: 10.1007/s00277-019-03710.
    >> Share

  152. LEVI M, Simonetti M, Marconi E, Brignoli O, et al
    Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries.
    Ann Hematol. 2019 May 9. pii: 10.1007/s00277-019-03707.
    >> Share

  153. CANNIZZO E, Raia M, De Propris MS, Triolo A, et al
    Features, reason for testing, and changes with time of 583 paroxysmal nocturnal hemoglobinuria clones from 529 patients: a multicenter Italian study.
    Ann Hematol. 2019;98:1083-1093.
    >> Share

  154. CHALOEMWONG J, Tantiworawit A, Rattanathammethee T, Chai-Adisaksopha C, et al
    Hyperuricemia, urine uric excretion, and associated complications in thalassemia patients.
    Ann Hematol. 2019;98:1101-1110.
    >> Share

    April 2019
  155. BAKR S, Khorshied M, Talha N, Jaffer KY, et al
    Implication of HMOX1 and CCR5 genotypes on clinical phenotype of Egyptian patients with sickle cell anemia.
    Ann Hematol. 2019 Apr 27. pii: 10.1007/s00277-019-03697.
    >> Share

  156. LANGER AL, Leader A, Kim-Schulze S, Ginzburg Y, et al
    Inhaled steroids associated with decreased macrophage markers in nonasthmatic individuals with sickle cell disease in a randomized trial.
    Ann Hematol. 2019;98:841-849.
    >> Share

  157. TAN CW, Wong WH, Idros R, Chan YH, et al
    Role of platelets in thrombin generation amongst patients with non-transfusion-dependent thalassaemia.
    Ann Hematol. 2019;98:861-868.
    >> Share

  158. BRANCALEONI V, Moukhadder HM, Consonni D, Koussa S, et al
    Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes.
    Ann Hematol. 2019;98:833-840.
    >> Share

  159. PATEL K, Bhivandkar S, Desai R, Antin T, et al
    The burden of psychiatric illnesses in adult patients with beta-thalassemia: a 5-year nationwide inpatient evaluation in the United States.
    Ann Hematol. 2019;98:851-860.
    >> Share

    March 2019
  160. AMES NJ, Barb JJ, Ranucci A, Kim H, et al
    The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study.
    Ann Hematol. 2019 Mar 27. pii: 10.1007/s00277-019-03599.
    >> Share

  161. ECSEDI M, Lengline E, Knol-Bout C, Bosman P, et al
    Use of eltrombopag in aplastic anemia in Europe.
    Ann Hematol. 2019 Mar 26. pii: 10.1007/s00277-019-03652.
    >> Share

  162. CHENG H, Wang X, Zhou D, Cao J, et al
    Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia.
    Ann Hematol. 2019 Mar 20. pii: 10.1007/s00277-019-03658.
    >> Share

  163. PAPADATOU I, Lagousi T, Kattamis A, Spoulou V, et al
    Antibody persistence 5 years after a 13-valent pneumococcal conjugate vaccine in asplenic patients with beta-thalassemia: assessing the need for booster.
    Ann Hematol. 2019;98:775-779.
    >> Share

  164. AL-SAWAF O, Kohler P, Eichenauer DA, Boll B, et al
    Management of an adult patient with sickle cell disease and acute chest syndrome by veno-venous extracorporeal membrane oxygenation.
    Ann Hematol. 2019;98:789-791.
    >> Share

    February 2019
  165. ZHANG H, Wan W, Liu X, Wen C, et al
    A case report of congenital erythropoietic anemia II in China with a novel mutation.
    Ann Hematol. 2019 Feb 12. pii: 10.1007/s00277-019-03612.
    >> Share

  166. BISWAS S, Nag A, Ghosh K, Ray R, et al
    Genetic determinants related to pharmacological induction of foetal haemoglobin in transfusion-dependent HbE-beta thalassaemia.
    Ann Hematol. 2019;98:289-299.
    >> Share

  167. MANAKENG K, Prasertphol P, Phongpao K, Chuncharunee S, et al
    Elevated levels of platelet- and red cell-derived extracellular vesicles in transfusion-dependent beta-thalassemia/HbE patients with pulmonary arterial hypertension.
    Ann Hematol. 2019;98:281-288.
    >> Share

    January 2019
  168. CHEN X, Hu J, Zhu J, Xu W, et al
    Severe hemolytic anemia due to combined alpha thalassemia and de novo Hemoglobin Sabine.
    Ann Hematol. 2019 Jan 23. pii: 10.1007/s00277-019-03617.
    >> Share

  169. LOBITZ S, Klein J, Brose A, Blankenstein O, et al
    Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns.
    Ann Hematol. 2019;98:47-53.
    >> Share

  170. MENG LL, Yuan SM, Tu CF, Lin G, et al
    Next-generation sequencing identified a novel SPTB frameshift insertion causing hereditary spherocytosis in China.
    Ann Hematol. 2019;98:223-226.
    >> Share

    December 2018
  171. RINELLI M, Bellacchio E, Berardinelli F, Pascolini G, et al
    Correction to: Structural modeling of a novel TERC variant in a patient with aplastic anemia and short telomeres.
    Ann Hematol. 2018 Dec 14. pii: 10.1007/s00277-018-3581.
    >> Share

  172. LAFARGE A, Bertinchamp R, Pichereau C, Valade S, et al
    Prognosis of autoimmune hemolytic anemia in critically ill patients.
    Ann Hematol. 2018 Dec 10. pii: 10.1007/s00277-018-3553.
    >> Share

  173. HOSOKAWA K, Sugimori C, Ishiyama K, Takamatsu H, et al
    Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failure.
    Ann Hematol. 2018;97:2289-2297.
    >> Share

    November 2018
  174. AKRAM Z, Ahmed P, Kajigaya S, Satti TM, et al
    Epidemiological, clinical and genetic characterization of aplastic anemia patients in Pakistan.
    Ann Hematol. 2018 Nov 13. pii: 10.1007/s00277-018-3542.
    >> Share

  175. LONG Z, Yu F, Du Y, Li H, et al
    Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus.
    Ann Hematol. 2018;97:2047-2054.
    >> Share

  176. SHALLIS RM, Xu ML, Curtis SA, Medoff E, et al
    Conviction in the face of affliction: a case series of Jehovah's Witnesses with myeloid malignancies.
    Ann Hematol. 2018;97:2245-2248.
    >> Share

  177. OLIVEIRA CC, Rocha JTQ, Silva GF, Biglia B, et al
    Would you think of histiocytic sarcoma in this fine-needle aspiration?
    Ann Hematol. 2018;97:2257-2259.
    >> Share

  178. GUIRAT DHOUIB N, Khaled MB, Ouederni M, Besbes H, et al
    Hypertransaminasemia revealing a clinically silent muscular dystrophy in a child with sickle cell disease.
    Ann Hematol. 2018;97:2261-2262.
    >> Share

    October 2018
  179. YABE M, Koike T, Ohtsubo K, Imai E, et al
    Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.
    Ann Hematol. 2018 Oct 27. pii: 10.1007/s00277-018-3517.
    >> Share

  180. WANG Z-, Yu H-, Cao F-, Liu Z-, et al
    Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children.
    Ann Hematol. 2018 Oct 19. pii: 10.1007/s00277-018-3523.
    >> Share

  181. MAKISHIMA K, Obara N, Ishitsuka K, Sukegawa S, et al
    High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease.
    Ann Hematol. 2018 Oct 15. pii: 10.1007/s00277-018-3521.
    >> Share

  182. REN Q, Zhou YL, Wang L, Chen YS, et al
    Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia.
    Ann Hematol. 2018;97:1933-1939.
    >> Share

  183. HAGHPANAH S, Zarei T, Eshghi P, Zekavat O, et al
    Efficacy and safety of resveratrol, an oral hemoglobin F-augmenting agent, in patients with beta-thalassemia intermedia.
    Ann Hematol. 2018;97:1919-1924.
    >> Share

  184. RICCHI P, Meloni A, Pistoia L, Spasiano A, et al
    The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network.
    Ann Hematol. 2018;97:1925-1932.
    >> Share

  185. FUJITA Y, Nakazato T, Ito C, Masuda K, et al
    A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment.
    Ann Hematol. 2018;97:2009-2010.
    >> Share

    September 2018
  186. LI SS, Hsu YT, Chang C, Lee SC, et al
    Incidence and treatment outcome of aplastic anemia in Taiwan-real-world data from single-institute experience and a nationwide population-based database.
    Ann Hematol. 2018 Sep 3. pii: 10.1007/s00277-018-3486.
    >> Share

  187. SHAH S, Jain P, Shah K, Patel K, et al
    Immunosuppressive therapy for aplastic anemia: a single-center experience from western India.
    Ann Hematol. 2018 Sep 1. pii: 10.1007/s00277-018-3487.
    >> Share

  188. CARPIO A, Merino A, Rodriguez-Tajes S, Reverter E, et al
    Massive hemolysis complicating acute granulomatous hepatitis.
    Ann Hematol. 2018;97:1741-1742.
    >> Share

  189. KALANTRI SA, Ray R, Chattopadhyay A, Bhattacharjee S, et al
    Efficacy of decitabine as hemoglobin F inducer in HbE/beta-thalassemia.
    Ann Hematol. 2018;97:1689-1694.
    >> Share

    August 2018
  190. FUREDER W, Sperr WR, Gleixner K, Thalhammer R, et al
    Major response of PNH to an AML chemotherapy protocol.
    Ann Hematol. 2018;97:1487-1488.
    >> Share

  191. YASUNAGA M, Taoka K, Nakagawa H, Yamada A, et al
    Eculizumab treatment for ischemic enteritis accompanied with paroxysmal nocturnal hemoglobinuria: a case report and literature review.
    Ann Hematol. 2018;97:1513-1515.
    >> Share

    July 2018
  192. YAMAMOTO A, Meguri Y, Fukuda A, Kambara Y, et al
    A case of reversible cerebral vasoconstriction syndrome developing during treatment of adult aplastic anemia.
    Ann Hematol. 2018 Jul 10. pii: 10.1007/s00277-018-3430.
    >> Share

  193. RINELLI M, Bellacchio E, Berardinelli F, Pascolini G, et al
    Structural modeling of a novel TERC variant in a patient with aplastic anemia and short telomeres.
    Ann Hematol. 2018 Jul 6. pii: 10.1007/s00277-018-3415.
    >> Share

  194. CLE DV, Atta EH, Dias DSP, Lima CBL, et al
    Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
    Ann Hematol. 2018 Jul 5. pii: 10.1007/s00277-018-3416.
    >> Share

    June 2018
  195. MYINT ZW, Oo TH, Thein KZ, Tun AM, et al
    Copper deficiency anemia: review article.
    Ann Hematol. 2018 Jun 29. pii: 10.1007/s00277-018-3407.
    >> Share

  196. ARANDA N, Bedmar C, Arija V, Jardi C, et al
    Serum hepcidin levels, iron status, and HFE gene alterations during the first year of life in healthy Spanish infants.
    Ann Hematol. 2018;97:1071-1080.
    >> Share

    May 2018
  197. BOHME T, Medinger M, Suenderhauf C, Speer O, et al
    Severe anemia after trans-catheter arterial chemoembolization-an unusual presentation of hemoglobin Zurich.
    Ann Hematol. 2018 May 8. pii: 10.1007/s00277-018-3353.
    >> Share

  198. CHATTERJEE T, Chakravarty A, Chakravarty S
    Hydroxyurea responses in clinically varied beta, HbE-beta thalassaemia and sickle cell anaemia patients of Eastern India.
    Ann Hematol. 2018;97:893-898.
    >> Share

  199. NEMTSAS P, Arnaoutoglou M, Perifanis V, Koutsouraki E, et al
    Polyneuropathy and myopathy in beta-thalassemia major patients.
    Ann Hematol. 2018;97:899-904.
    >> Share

  200. RAGHUNATHAN VM, Whitesell PL, Lim SH
    Sleep-disordered breathing in patients with sickle cell disease.
    Ann Hematol. 2018;97:755-762.
    >> Share

    April 2018
  201. MICHALAK SS, Rupa-Matysek J, Gil L
    Comorbidities, repeated hospitalizations, and age >/= 80 years as indicators of anemia development in the older population.
    Ann Hematol. 2018 Apr 9. pii: 10.1007/s00277-018-3321.
    >> Share

  202. MIRLOHI MS, Yaghooti H, Shirali S, Aminasnafi A, et al
    Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with beta-thalassemia major.
    Ann Hematol. 2018;97:679-684.
    >> Share

    March 2018
  203. RODGERS GM, Gilreath JA
    Eltrombopag as initial monotherapy for severe aplastic anemia-a case report.
    Ann Hematol. 2018 Mar 20. pii: 10.1007/s00277-018-3303.
    >> Share

    February 2018
  204. SUZUKI Y, Koya J, Ebisawa K, Abe H, et al
    Sequential development of monoclonal B cell lymphocytosis-derived small lymphocytic lymphoma and plasma cell leukemia.
    Ann Hematol. 2018 Feb 7. pii: 10.1007/s00277-018-3248.
    >> Share

  205. GHAVAMZADEH A, Sotoudeh M, Hashemi Taheri AP, Alimoghaddam K, et al
    Liver fibrosis alleviation after co-transplantation of hematopoietic stem cells with mesenchymal stem cells in patients with thalassemia major.
    Ann Hematol. 2018;97:327-334.
    >> Share

    January 2018
  206. ZHAO L, Zhu H, Han B, Wang L, et al
    Influence of genetic polymorphisms of IL23R, STAT3, IL12B, and STAT4 on the risk of aplastic anemia and the effect of immunosuppressive therapy.
    Ann Hematol. 2018 Jan 12. pii: 10.1007/s00277-018-3227.
    >> Share

    December 2017
  207. VAN ZEVENTER IA, Schreurs JWGM, van den Berg E, Mulder AB, et al
    Efficacy of antithymocyte globulin as first-line treatment for aplastic anemia-a single-center experience.
    Ann Hematol. 2017 Dec 16. pii: 10.1007/s00277-017-3201.
    >> Share

    November 2017
  208. SMART LR, Ambrose EE, Raphael KC, Hokororo A, et al
    Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.
    Ann Hematol. 2017 Nov 16. doi: 10.1007/s00277-017-3182.
    >> Share

  209. VISWESHWAR N, Jaglal M, Sokol L, Zuckerman K, et al
    Chemotherapy-related anemia.
    Ann Hematol. 2017 Nov 4. doi: 10.1007/s00277-017-3155.
    >> Share

  210. FERRAO J, Silva M, Goncalves L, Gomes S, et al
    Widening the spectrum of deletions and molecular mechanisms underlying alpha-thalassemia.
    Ann Hematol. 2017;96:1921-1929.
    >> Share

  211. KLONIZAKIS P, Klaassen R, Sousos N, Liakos A, et al
    Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients.
    Ann Hematol. 2017;96:1937-1944.
    >> Share

  212. MAIRA D, Cassinerio E, Marcon A, Mancarella M, et al
    Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT).
    Ann Hematol. 2017;96:1931-1936.
    >> Share

    October 2017
  213. HOUSTON BL, Jayakar J, Wells RA, Lenis M, et al
    A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry.
    Ann Hematol. 2017 Oct 3. doi: 10.1007/s00277-017-3137.
    >> Share

  214. VILLEGAS A, Nunez R, Gaya A, Cuevas-Ruiz MV, et al
    Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry.
    Ann Hematol. 2017;96:1727-1733.
    >> Share

    September 2017
  215. YANG N, Chen J, Zhang H, Dai Z, et al
    Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naive aplastic anemia: a systematic review and meta-analysis.
    Ann Hematol. 2017 Sep 30. doi: 10.1007/s00277-017-3136.
    >> Share

  216. KEDAR P, Parmar V, Devendra R, Gupta V, et al
    Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations.
    Ann Hematol. 2017 Sep 7. doi: 10.1007/s00277-017-3116.
    >> Share

  217. GRAZIADEI G, Casoni FM, Annoni F, Cortinovis I, et al
    Transcranial color Doppler in stroke-free adult patients with sickle cell disease.
    Ann Hematol. 2017;96:1547-1555.
    >> Share

  218. RICCHI P, Meloni A, Costantini S, Spasiano A, et al
    Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia.
    Ann Hematol. 2017;96:1541-1546.
    >> Share

  219. RODEGHIERO F, Carli G
    Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.
    Ann Hematol. 2017;96:1421-1434.
    >> Share

    August 2017
  220. FUJIWARA T, Fukuhara N, Ichikawa S, Kobayashi M, et al
    A novel heterozygous ALAS2 mutation in a female with macrocytic sideroblastic anemia resembling myelodysplastic syndrome with ring sideroblasts: a case report and literature review.
    Ann Hematol. 2017 Aug 24. doi: 10.1007/s00277-017-3106.
    >> Share

  221. ATTA EH, Lima CBL, Dias DSP, Cle DV, et al
    Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
    Ann Hematol. 2017 Aug 16. doi: 10.1007/s00277-017-3086.
    >> Share

  222. LI Q, Luo C, Luo C, Wang J, et al
    Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.
    Ann Hematol. 2017;96:1389-1397.
    >> Share

  223. WIEBKING V, Hutker S, Schmid I, Immler S, et al
    Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Ann Hematol. 2017;96:1373-1377.
    >> Share

    July 2017
  224. KLAIHMON P, Vimonpatranon S, Noulsri E, Lertthammakiat S, et al
    Normalized levels of red blood cells expressing phosphatidylserine, their microparticles, and activated platelets in young patients with beta-thalassemia following bone marrow transplantation.
    Ann Hematol. 2017 Jul 26. doi: 10.1007/s00277-017-3070.
    >> Share

  225. ANTUNES FD, Propheta VGS, Vasconcelos HA, Cipolotti R, et al
    Neuropathic pain in patients with sickle cell disease: a cross-sectional study assessing teens and young adults.
    Ann Hematol. 2017;96:1121-1125.
    >> Share

    June 2017
  226. DE LACERDA MP, Guedes NR, Yamakawa PE, Pereira AD, et al
    Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with (del17p).
    Ann Hematol. 2017 Jun 9. doi: 10.1007/s00277-017-3039.
    >> Share

  227. OKA S, Ono K, Nohgawa M
    Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation.
    Ann Hematol. 2017 Jun 2. doi: 10.1007/s00277-017-3032.
    >> Share

  228. TESSOULIN B, Thomare P, Delande E, Moynard J, et al
    Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.
    Ann Hematol. 2017;96:943-950.
    >> Share

  229. SURAPOLCHAI P, Chuansumrit A, Sirachainan N, Kadegasem P, et al
    A molecular study on the role of alpha-hemoglobin-stabilizing protein in hemoglobin H disease.
    Ann Hematol. 2017;96:1005-1014.
    >> Share

  230. BALDINI M, Marcon A, Ulivieri FM, Seghezzi S, et al
    Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables.
    Ann Hematol. 2017;96:995-1003.
    >> Share

  231. CASSINERIO E, Baldini IM, Alameddine RS, Marcon A, et al
    Pregnancy in patients with thalassemia major: a cohort study and conclusions for an adequate care management approach.
    Ann Hematol. 2017;96:1015-1021.
    >> Share

    May 2017
  232. CASTELLI R, Sciara S, Lambertenghi Deliliers G, Pantaleo G, et al
    Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study.
    Ann Hematol. 2017;96:779-786.
    >> Share

  233. LAI YK, Lai NM, Lee SW
    Glucose-6-phosphate dehydrogenase deficiency and risk of diabetes: a systematic review and meta-analysis.
    Ann Hematol. 2017;96:839-845.
    >> Share

    April 2017
  234. YOUSSRY I, Soliman N, Ghamrawy M, Samy RM, et al
    Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients.
    Ann Hematol. 2017;96:597-603.
    >> Share

  235. ALASHKAR F, Vance C, Herich-Terhurne D, Preising N, et al
    Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab.
    Ann Hematol. 2017;96:589-596.
    >> Share

  236. CHEN M, Zhuang J, Zhou D, Xu Y, et al
    Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection.
    Ann Hematol. 2017;96:581-587.
    >> Share

    March 2017
  237. GREGORY GP, Farrell A, Brown S
    Cold agglutinin disease complicated by acrocyanosis and necrosis.
    Ann Hematol. 2017;96:509-510.
    >> Share

    February 2017
  238. PUIGVI L, Baumann T, Fernandez S, Castro P, et al
    Massive erythrophagocytosis by peripheral monocytes and neutrophils in parvovirus-B19 autoimmune hemolytic anemia.
    Ann Hematol. 2017 Feb 21. doi: 10.1007/s00277-017-2957.
    >> Share

  239. KNUPPEL E, Medinger M, Stehle G, Infanti L, et al
    Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure.
    Ann Hematol. 2017 Feb 3. doi: 10.1007/s00277-017-2936.
    >> Share

  240. KLAIHMON P, Phongpao K, Kheansaard W, Noulsri E, et al
    Microparticles from splenectomized beta-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential.
    Ann Hematol. 2017;96:189-198.
    >> Share

  241. WANG HC, Hsieh LL, Liu YC, Hsiao HH, et al
    The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan.
    Ann Hematol. 2017;96:183-188.
    >> Share

  242. BURKHARDT L, Lobitz S, Koustenis E, Rueckriegel SM, et al
    Cognitive and fine motor deficits in a pediatric sickle cell disease cohort of mixed ethnic origin.
    Ann Hematol. 2017;96:199-213.
    >> Share

    January 2017
  243. OUEDERNI M, Ben Khaled M, Mellouli F, Ben Fraj E, et al
    Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.
    Ann Hematol. 2017;96:133-139.
    >> Share

  244. BOGUSLAWSKA DM, Heger E, Machnicka B, Skulski M, et al
    A new frameshift mutation of the beta-spectrin gene associated with hereditary spherocytosis.
    Ann Hematol. 2017;96:163-165.
    >> Share

  245. AL NAJJAR S, Adam S, Ahmed N, Qari M, et al
    Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
    Ann Hematol. 2017;96:141-146.
    >> Share

    December 2016
  246. LIANG XH, Rong L, He G, He H, et al
    Polymorphisms of the TGF-beta1 gene and the risk of acquired aplastic anemia in a Chinese population.
    Ann Hematol. 2016.
    >> Share

  247. OH DH, Motorna O, Kong JB, Brown S, et al
    Linezolid-associated reticulocytopenia.
    Ann Hematol. 2016;95:2095-2097.
    >> Share

    November 2016
  248. GROTH M, Singer S, Niedeggen C, Petermann-Meyer A, et al
    Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II.
    Ann Hematol. 2016.
    >> Share

    October 2016
  249. ZHANG XH, Wang QM, Chen H, Chen YH, et al
    Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation.
    Ann Hematol. 2016;95:1637-43.
    >> Share

  250. CRISP RL, Maltaneri RE, Vittori DC, Solari L, et al
    Red blood cell aquaporin-1 expression is decreased in hereditary spherocytosis.
    Ann Hematol. 2016;95:1595-601.
    >> Share

  251. PHONDEECHAREON T, Wattanapanitch M, U-Pratya Y, Damkham C, et al
    Generation of induced pluripotent stem cells as a potential source of hematopoietic stem cells for transplant in PNH patients.
    Ann Hematol. 2016;95:1617-25.
    >> Share

  252. URESHINO H, Miyahara M
    Unusual co-occurrence of Evans syndrome and pure red cell aplasia in elderly patient with prostate cancer.
    Ann Hematol. 2016;95:1743-4.
    >> Share

  253. HUANG Y, Wang M, Yu C, Lei Y, et al
    Clinical presentation of the hemoglobin Youngstown variant in a Chinese family.
    Ann Hematol. 2016;95:1925-7.
    >> Share

  254. BALAIAN E, Schuster C, Schonefeldt C, Germing U, et al
    Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q.
    Ann Hematol. 2016;95:1805-10.
    >> Share

    September 2016
  255. VAGACE JM, Cardesa R, Corbacho A, Vazquez T, et al
    Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia.
    Ann Hematol. 2016;95:1419-27.
    >> Share

  256. LANZA F, Lazzari MC, Brambilla P, Di Martino G, et al
    An unusual association of paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, and diffuse large B-cell non-Hodgkin lymphoma in a Caucasian man.
    Ann Hematol. 2016;95:1555-7.
    >> Share

  257. HAGIWARA K, Kamesaki T, Kakimoto T, Fukushima K, et al
    Long-term follow-up of non-syphilitic paroxysmal cold hemoglobinuria in an adult.
    Ann Hematol. 2016;95:1547-9.
    >> Share

    August 2016
  258. ZAREI T, Haghpanah S, Parand S, Moravej H, et al
    Evaluation of bone mineral density in patients with hemoglobin H disease.
    Ann Hematol. 2016;95:1329-32.
    >> Share

  259. KARIMI M, Haghpanah S, Pishdad P, Rachmilewitz EA, et al
    Frequency of silent cerebral ischemia in patients with transfusion-dependent beta-thalassemia major compared to healthy individuals.
    Ann Hematol. 2016;95:1387.
    >> Share

  260. ZAFARI M, Kosaryan M, Gill P, Alipour A, et al
    Non-invasive prenatal diagnosis of beta-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis.
    Ann Hematol. 2016;95:1341-50.
    >> Share

    June 2016
  261. UPADHYE D, Jain D, Trivedi Y, Nadkarni A, et al
    Influence of single nucleotide polymorphisms in the BCL11A and HBS1L-MYB gene on the HbF levels and clinical severity of sickle cell anaemia patients.
    Ann Hematol. 2016;95:1201-3.
    >> Share

    May 2016
  262. MUSA BM, Galadanci NA, Coker M, Bussell S, et al
    The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.
    Ann Hematol. 2016.
    >> Share

  263. KARACAOGLU PK, Asma S, Korur A, Solmaz S, et al
    East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients.
    Ann Hematol. 2016;95:993-1000.
    >> Share

  264. CARLI G, Visco C, Falisi E, Perbellini O, et al
    Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
    Ann Hematol. 2016;95:863-70.
    >> Share

  265. PIERINI A, Mancusi A, Terenzi A, Massei MS, et al
    New mechanism of lymphoma-induced bone marrow aplasia.
    Ann Hematol. 2016;95:1013-5.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016